Cancer mortality in workers exposed to organochlorine compounds in the pulp and paper industry: an international collaborative study.

The objective of this study was to evaluate cancer mortality in pulp and paper industry workers exposed to chlorinated organic compounds. We assembled a multinational cohort of workers employed between 1920 and 1996 in 11 countries. Exposure to both volatile and nonvolatile organochlorine compounds was estimated at the department level using an exposure matrix. We conducted a standardized mortality ratio (SMR) analysis based on age and calendar-period-specific national mortality rates and a Poisson regression analysis. The study population consisted of 60,468 workers. Workers exposed to volatile organochlorines experienced a deficit of all-cause [SMR = 0.91; 95% confidence interval (CI), 0.89-0.93] and all-cancer (SMR = 0.93; 95% CI, 0.89-0.97) mortality, with no evidence of increased risks for any cancer of a priori interest. There was a weak, but statistically significant, trend of increasing risk of all-cancer mortality with increasing weighted cumulative exposure. A similar deficit in all-cause (SMR = 0.94; 95% CI, 0.91-0.96) and all-cancer (SMR = 0.94; 95% CI, 0.89-1.00) mortality was observed in those exposed to nonvolatile organochlorines. No excess risk was observed in cancers of a priori interest, although mortality from Hodgkin disease was elevated (SMR = 1.76; 95% CI, 1.02-2.82). In this study we found little evidence that exposure to organochlorines at the levels experienced in the pulp and paper industry is associated with an increased risk of cancer, apart from a weak but significant association between all-cancer mortality and weighted cumulative volatile organochlorine exposure. Key words: epidemiology, mortality, neoplasms, organochlorines, pulp and paper industry. Environ Health Perspect 114:1007-1012 (2006). doi:10.1289/ehp.8588 available via http://dx.doi.org/ [Online 13 March 2006]

**********

Pulp and paper production workers have been exposed to a complex mixture of hazardous substances, including known or suspected carcinogens such as wood dust, various wood extracts and associated bioaerosols, reduced sulfur compounds, talc, formaldehyde, combustion products, epichlorohydrin, acid mists, auramine and other benzidine-based dyes, and a range of chlorinated organic compounds (Kauppinen et al. 1997, 2002). The patterns of exposure in the industry are complicated because of the range of different processes that have been used over time in the various stages of pulp and paper manufacture, which together with the relatively small numbers of workers within specific departments has limited the power of epidemiologic studies of mill-based cohorts. A number of studies, nevertheless, have suggested increased risks of gastrointestinal cancers (Henneberger et al. 1989; Milham and Demers 1984), respiratory system cancers (Milham and Demers 1984; Siemiatycki et al. 1986; Toren et al. 1991), and certain lymphatic and hematopoietic neoplasms (Coggon et al. 1997; Matanoski et al. 1998) in pulp and paper industry workers. Despite the large number of studies conducted, there is still uncertainty about the exact nature and extent of cancer risks associated with work in this industry (Toren 1996).

The International Agency for Research on Cancer (IARC) therefore coordinated an international collaborative cohort study to investigate mortality and cancer incidence in the pulp, paper, paperboard, recycled paper, and paper product industries. This study has combined cohorts from 13 countries, consisting of 98,665 workers (2,110,913 person-years), and included the development of a comprehensive database of exposure measurements for the retrospective assessment of study participants' exposure (Kauppinen et al. 1997, 2002). The results for mortality and incidence in selected national cohorts (Fassa et al. 1998; Henneberger and Lax 1998; Henneberger et al. 1989; Jappinen and Pukkala 1991; Jappinen and Tola 1986; Langseth and Andersen 1999, 2000; McLean et al. 2002; Rix et al. 1997, 1998; Sala-Serra et al. 1996; Szadkowska-Stanczyk et al. 1997; Szadkowska-Stanczyk and Szymczak 2001; Wild et al. 1998), and for separate analyses of exposure to sulfur dioxide (Lee et al. 2002) and asbestos (Carel et al. 2002) in the overall cohort, have been reported.

Workers in this industry experience exposure to chlorinated organic compounds, both volatile chlorinated hydrocarbons such as trichloroethylene, perchloroethylene, dichloromethane, and trichloromethane, and nonvolatile organochlorine compounds such as chlorophenols and their salts [pentachloro-phenol (PCP)], polychlorinated biphenyls (PCBs), and polychlorinated dibenzodioxins (PCDDs) or polychlorinated dibenzofurans (PCDFs). IARC has classified the volatile organochlorines trichloroethylene and perchloroethylene as probably carcinogenic to humans (group 2A) on the basis of limited evidence in humans of excess risks of cancer of the liver and biliary tract, non-Hodgkin lymphoma (NHL), and esophageal and cervical cancer, and dichloromethane and trichloromethane as possibly carcinogenic to humans (group 2B) based on sufficient evidence for carcinogenicity in animals (Siemiatycki et al. 2004). Of the nonvolatile organochlorine compounds, IARC has classified the 2,3,7,8-substituted tetrachlorodibenzo-para-dioxins (TCDDs) as carcinogenic to humans (group 1) on the basis of both mechanistic evidence and limited evidence in humans of excess risk of all cancers combined rather than for any specific site cancer; PCBs as probably carcinogenic to humans (group 2A) because of limited evidence of excess cancers of the liver and biliary tract and of lymphatic and hematopoietic tissues; and PCPs and their sodium salts as possibly carcinogenic to humans (group 2B) based on findings of excess risk of soft tissue sarcoma and NHL (Siemiatycki et al. 2004). The aim of the present study was to investigate the association between cancer mortality and exposure to chlorinated organic compounds in the IARC pulp and paper workers cohort.

Materials and Methods

Workers employed for at least 1 year in the pulp and paper industry in 13 countries during the period 1920-1996 were included in the overall IARC study, with cohorts from Denmark, Finland, France, Japan, New Zealand, Norway, Poland, Spain, Sweden, Scotland, and the United States included in this analysis of organochlorine exposure. Brazil and South Africa were excluded from this analysis because of inadequacies in the quality of mortality data. Cohort members were identified from company personnel records, with work histories available for the full period of employment in that company.

The exposure assessment procedure used for this study has been described in detail elsewhere (Kauppinen et al. 1997, 2002). Briefly, an international panel of industrial hygiene experts used their professional judgment to estimate exposure over different time periods to 27 main agents at the level of department (but not specific job titles within departments) in each of the mills studied, based on detailed company questionnaires on current and historical raw materials and production processes, and < 31,000 existing (mainly unpublished) occupational exposure measurements. Where sufficient measurement data were available, the expected prevalence and level of exposure to specific agents were quantified, and then depending on the range of estimated exposure levels for each agent, limits for low-, medium-, and high-exposure categories were assigned. For these agents, each worker's weighted cumulative exposure was then estimated by combining the prevalence, level, and duration of exposure. Where only limited measurement data were available, a qualitative assessment of likely, unlikely, or unknown potential for exposure was made.

Exposure to volatile organochlorine compounds was defined as inhalatory exposure to chlorinated solvents or other specified compounds (indicator agents being trichloroethylene, perchloroethylene, dichloromethane, and trichloromethane) at a level exceeding the nonoccupational background level. These substances have been used as cleaning and degreasing agents in most departments, with the highest exposures occurring in maintenance, repair, and cleaning operations, and medium exposures in sulfate pulp and pulp bleaching departments. The high-exposure category was defined as workers in those departments in which > 50% were exposed and in which the mean level of exposure over the work year was estimated to exceed 1 ppm for trichloromethane, 2.5 ppm for perchloro-ethylene, and 5 ppm for dichloromethane and trichloroethylene [all 1/10th of the threshold limit value of the American Conference of Governmental Industrial Hygienists (ACGIH 2005)].

Nonvolatile organochlorine exposure was assessed in qualitative terms as ever/never exposed, with exposure defined as potential dermal or inhalatory exposure to PCP or its salts, PCBs, PCDDs, PCDFs, or other nonvolatile organochlorine compounds exceeding the nonoccupational long-term background level. PCP has been used to prevent sapstain in softwoods used for pulp, with consequent worker exposure during pulping operations. Exposure to PCBs is most likely to have occurred during maintenance and repair of electrical or hydraulic equipment. Both PCP and PCBs contain PCDDs and PCDFs as contaminants of their manufacture, and PCDDs and PCDFs may also be formed as by-products of the bleaching of pulp with chlorine compounds, resulting in occupational exposure both during bleaching and downstream for those involved in paper production (Krishnan 1990).

Workers were followed up for mortality according to procedures specific to each country. The period of follow-up varied among countries, ranging from 12 to 50 years. Details on periods of employment and follow-up are reported in Table 1. Causes of death were either abstracted from death certificates or obtained from mortality registries, and coded according to the International Classification of Diseases, 9th Revision (ICD-9) [World Health Organization (WHO) 1975]. Tabulation of person-years started at the beginning of the observation period or on day 1 of the second year of employment if this occurred after the start of the observation period. Standardized mortality ratios (SMRs) were calculated as the ratio of observed to expected deaths, with expected deaths being computed by multiplying the person-years in each sex-specific, age-specific, and 5-year calendar-period-specific stratum by the national reference rates using the Person Years program (Coleman et al. 1986). National rates were derived from the WHO Mortality Database (WHO 2001). Ninety-five percent confidence intervals (CIs) of the SMR were calculated under the assumption that the observed numbers of deaths follow a Poisson distribution. Internal analyses were conducted according to years since first employment (< 18, 18-27, 28-37, > 38 years) and duration of exposure (< 4, 4-10, 11-21, > 22 years), and for the volatile organochlorines also by cumulative exposure ([SIGMA] level x duration; < 3, 3-9, 10-29, > 30 ppm-years) and weighted cumulative exposure ([SIGMA] prevalence x level x duration: < 1, 1-17, > 18 ppm-years), with cut points for continuous measurements of exposure set at quartiles or tertiles depending on numbers available. Tests for linear trend in SMRs were performed using a method described by Breslow and Day (1987).

Poisson regression analysis was used to examine internal dose-response relations associated with exposure to volatile organochlorines and to explore the effect of potential confounding factors. Rate ratios (RRs) and 95% CIs derived from the analysis were adjusted for country, sex, age, calendar period, and employment status (i.e., whether person-years accumulated while workers were employed in the companies included in the study). The reference group for each RR was the first level of each variable.

Results

The distribution of study participants by exposure status and country is shown in Table 1. At the end of follow-up of the overall cohort, 79% of the workers were alive, 18% had died, 2% were lost to follow-up, and 1% had emigrated. Altogether, 60,468 workers (1,347,782 person-years) were classified according to volatile organochlorine exposure status, with 82% of the person-years classified as ever exposed and 17% (i.e., 9,628 workers or 229,434 person-years) as having high exposure. A total of 58,162 workers (1,259,780 person-years) were classified according to nonvolatile organochlorine exposure status, with 45% (i.e., 24,940 workers or 570,135 person-years) classified as ever exposed. There was significant overlap between the two exposure groups, with maintenance workers in particular often experiencing exposure to both volatile and nonvolatile organochlorines.

Cause-specific mortality for the workers classified according to exposure to volatile organochlorines is shown in Table 2. Among exposed workers there was a deficit of all causes of death (9,350 deaths; SMR = 0.91; 95% CI, 0.89-0.93) and of all malignant neoplasms (2,285 deaths; SMR = 0.93; 95% CI, 0.89-0.97). Of the cancers of a priori interest, there were reduced SMRs for cancer of the esophagus (45 deaths; SMR = 0.74; 95% CI, 0.54-0.99), liver (33 deaths; SMR = 0.76; 95% CI, 0.53-1.07), and cervix (17 deaths; SMR = 0.99; 95% CI, 0.58-1.59); for neoplasms of lymphatic or hematopoietic tissues (189 deaths; SMR = 0.94; 95% CI, 0.81-1.08); and for NHL (52 deaths; SMR = 0.86; 95% CI, 0.64-1.13). Statistically significant excess mortality from pleural neoplasms was observed in the exposed group (20 deaths; SMR = 2.00; 95% CI, 1.22-3.09), mostly due to the even larger excess observed in the highly exposed subjects (8 deaths; SMR = 3.67; 95% CI, 1.58-7.23) who were maintenance workers also exposed to asbestos. The elevation observed in those never exposed was virtually identical (4 deaths; SMR = 1.91; 95% CI, 0.52-4.90) to the exposed group, possibly also due to asbestos exposure. Other statistically significant findings included excess mortality from cancer of the penis and other male genital organs (7 deaths; SMR = 2.51; 95% CI, 1.01-5.17) in the exposed group, and cancer of other respiratory organs (4 deaths; SMR = 3.84; 95% CI, 1.05-9.84) in the highly exposed group. The results reported here are for the overall cohort including both men and women. In general, there was little difference in the findings between sexes, although the results among women were based on a relatively small number of deaths.

Cause-specific mortality for the workers classified according to exposure to nonvolatile organochlorines is shown in Table 3. All-cause mortality in the exposed workers was below expected (4,622 deaths; SMR = 0.94; 95% CI, 0.91-0.96), as was mortality from all cancer (1,145 deaths; SMR = 0.94; 95% CI, 0.89-1.00). Mortality from the other neoplasms of a priori interest was also below expected, including liver cancer (16 deaths; SMR = 0.69; 95% CI, 0.40-1.13), soft tissue sarcoma (4 deaths; SMR = 0.80; 95% CI, 0.22-2.04), lymphatic and hematopoietic tissue neoplasms in general (97 deaths; SMR = 0.99; 95% CI, 0.81-1.21), and NHL in particular (25 deaths; SMR = 0.86; 95% CI, 0.55-1.26). The only neoplasms showing elevated risks were penis and other cancer of male genital organs (5 deaths; SMR = 3.60; 95% CI, 1.17-8.40) and Hodgkin disease (17 deaths; SMR = 1.76; 95% CI, 1.02-2.82), and in both sites this was more than three times the rate observed in the workers never exposed. It is of interest to note, however, that the 3-fold excesses in risk of cancer of the penis and other male genital organs and of Hodgkin disease in workers not exposed to nonvolatile organochlorines are matched by deficits (of a similar magnitude) in risk of pleural and other respiratory cancers in those not exposed.

No consistent pattern of increasing risk with increasing exposure to either volatile or nonvolatile organochlorines was apparent for any cause of death after stratification by duration of employment or by years since first exposure to both volatile and nonvolatile compounds, or by weighted cumulative exposure to volatile organochlorines (data not shown). The Poisson regression analyses stratified according to weighted cumulative volatile organochlorine exposure (shown in Table 4), and adjusted for sex, age, employment status, calendar year, and country, showed a weak (p = 0.002) trend of increasing risk of mortality from all cancer combined with increasing weighted cumulative exposure to volatile organochlorines (< 1 ppm-years: RR = 1; 1-17 ppm-years: RR = 1.12; 95% CI, 1.01-1.24; > 18 ppm-years: RR = 1.19; 95% CI, 1.016-1.34). No other site of a priori interest showed a statistically significant trend of increasing risk, although nonsignificant increases were suggested for liver cancer and for cancer of the pleura. The risk estimates, and the positive trend, for cancer of the pleura were essentially unchanged after adjustment for either exposure to or high exposure to asbestos.

Discussion

In this large multicenter historical cohort study, which examined the risks associated with exposure to both volatile and nonvolatile organochlorines in the pulp and paper industry work environment, we found lower than expected overall mortality and all-cancer mortality rates. Internal comparisons based on duration of exposure and time since first exposure showed no consistent exposure-response trends of risk increasing with either volatile or nonvolatile organochlorines. A weak, but statistically significant, trend of increasing risk of all-cancer mortality with increasing weighted cumulative exposure to volatile organochlorines was observed. This finding is similar to the effect seen in other large cohorts with potential exposure to nonvolatile organochlorines contaminated with TCDD (Kogevinas et al. 1997) but has not previously been reported for volatile organochlorine exposure.

As in most historical cohort studies of industrial workers, we found a deficit in overall mortality and cancer mortality in this study compared with rates expected in the national populations. This is common in occupational cohort mortality studies and has been observed in previous studies of pulp and paper workers (Band et al. 2001; Coggon et al. 1997; Matanoski et al. 1998), due to the healthy worker effect that arises because healthy people are more likely to gain employment and to remain in employment (Checkoway et al. 2004). The healthy worker effect is generally weaker for cancer than for other causes of mortality, as observed in this study.

The assessment of exposure was based on a pulp and paper industry exposure matrix developed by an expert team of industrial hygienists familiar with the pulp and paper industry, although relatively few quantitative data were available on organochlorine exposure (Kauppinen 1997). Estimates of organochlorine exposure were therefore based largely on information available from company questionnaires about processes and raw materials used (e.g., time periods when chlorine bleaching was done or when PCBs were used in mill electrical equipment). Work histories were available only at the department level for most of the mills under study, so individual exposure estimates were based on the level and prevalence of exposure in the department worked in rather than on a more specific job title. The inability to take into account heterogeneity of exposure among workers in a department is likely to have resulted in significant nondifferential misclassification of exposure, resulting in a tendency to underestimate any true elevation of risk associated with exposure. In addition, because the exposure assessment for the nonvolatile organochlorines was qualitative, it was possible only to make internal comparisons based on the likelihood of ever being exposed rather than evaluating trends according to cumulative dose.

As with most historical cohort studies, there is also a lack of information on potential lifestyle confounders such as smoking. However, even for lung cancer, the relatively small differences in smoking status between groups of manual workers are unlikely to account for a relative risk of > 1.5 in studies involving a comparison with national mortality rates (Axelson 1978), and the confounding effect is even weaker for internal dose-response analyses (Siemiatycki et al. 1988). It is therefore unlikely that there is serious confounding by lifestyle factors in the present study, even regarding the findings for pleural cancer and other respiratory cancers. It is possible that the weak but statistically significant exposure-response relationship for all cancers associated with weighted cumulative exposure to volatile compounds could be due to confounding by lifestyle factors or to the exposure of many maintenance workers to other carcinogens, including asbestos.

Overall, we found little evidence of any increased risk of cancer mortality in pulp and paper workers exposed to organochlorines, apart from the weak but statistically significant exposure-response trend for cumulative exposure to volatile organochlorines. Although there is evidence of such an association for all cancers with exposure to phenoxy herbicides contaminated with TCDD (Kogevinas et al. 1997), we are not aware of any evidence suggesting such an association for volatile organochlorine exposure of the type that occurs in pulp and paper mills. Although statistically significant, the association was relatively weak, and this finding should therefore be regarded as preliminary and requiring further investigation.

We found little evidence of increased risks for specific cancer sites that have been previously associated with organochlorine exposure, including cancer of the esophagus, liver, cervix, and NHL for volatile organochlorines, and cancer of the liver, soft tissue sarcoma, lymphatic, and hematopoietic tissue and NHL for nonvolatile organochlorines. Instead, the only sites that showed significant excess risks in those exposed to volatile organochlorines were cancer of the pleura, "other respiratory," and "penis and other male genital organs," and for all three sites the risk was higher in those with high exposure. Interestingly, although the excess risk for cancer of penis and other male genital organs was also elevated in those with exposure to nonvolatile organochlorines, the risks for cancer of the pleura and other respiratory cancers were elevated only in those never exposed to nonvolatile organochlorines and below expected in those with exposure. For pleural cancer, this may be because many of the group classified as exposed to nonvolatile organochlorines were bleach plant operators, whereas the group with volatile organochlorine exposure were predominantly maintenance workers. So it is possible that these findings could be due to concomitant exposure to asbestos, because the highest exposures to these compounds occurred in maintenance, repair, and cleaning operations, and an excess risk of pleural cancer has already been reported in workers exposed to asbestos in this industry (Carel et al. 2002). Unfortunately, joint analyses of asbestos and organochlorine exposure were equivocal because most of the pleural and other respiratory cancers occurred in workers exposed to both factors, and there were insufficient numbers to determine whether there were increased risks in workers exposed to nonvolatile organochlorines alone. When the organochlorine findings were adjusted for asbestos exposure (data not shown), the RRs were essentially unchanged. Although the elevated risk observed for both cancers of penis and other male genital organs and other respiratory cancers was statistically significant, in both cases the CIs were wide and the small number of cases precluded further analysis. It is possible, therefore, that these are chance findings. Increased risks of Hodgkin disease, however, have been consistently reported among pulp mill workers (Milham and Demers 1984; Toren et al. 1996), woodworkers (McCunney 1999), and those with exposure to the herbicides 2,4-D (2,4-dichlorophenoxyacetic acid), 2,4,5-T (2,4,5-trichlorophenoxyacetic acid) and its contaminant TCDD, cacodylic acid, and picloram (Dich et al. 1997; Institute of Medicine 2000). The statistically significant increase in risk observed among workers with exposure to nonvolatile organochlorines in this cohort appears to be consistent with these earlier findings. Because the survival for NHL is relatively good, an analysis of incidence would have been more informative, but unfortunately cancer incidence data were available only from Denmark, Finland, New Zealand, Norway, and Sweden. The lack of incidence data and the small number of cases precluded any further analysis of this association.

In summary, there is little evidence that exposure to organochlorines at the levels experienced in the pulp and paper industry causes an increased risk of cancer, apart from a weakly statistically significant association with weighted cumulative volatile organochlorine exposure. There was little evidence of an increased risk for any specific cancer sites, apart from a statistically significant association between nonvolatile organochlorine exposure and Hodgkin disease and cancer of the pleura. The finding for pleural cancer is consistent with evidence that maintenance workers were exposed to asbestos.

REFERENCES

ACGIH. 2005. Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices. Cincinnati, OH: American Conference of Governmental Industrial Hygienists.

Axelson O. 1978. Aspects on confounding in occupational health epidemiology. Scand J Work Environ Health 4:98-102.

Band PR, Le ND, Fang R, Astrakianakis G, Bert J, Keefe A, et al. 2001. Cohort cancer incidence among pulp and paper mill workers in British Columbia. Scand J Work Environ Health 27:113-119.

Breslow NE, Day NE. 1987. Statistical Methods in Cancer Research, Volume II: The Design and Analysis of Cohort Studies. IARC Sci Pub 82:1-406.

Carel R, Boffetta P, Kauppinen T, Teschke K, Anderson A, Jappinen P, et al. 2002. Exposure to asbestos and lung and pleural cancer mortality among pulp and paper workers. J Occup Environ Med 44:579-584.

Checkoway H, Pearce NE, Kriebel D. 2004. Research Methods in Occupational Epidemiology. New York:Oxford University Press.

Coggon D, Wield G, Pannett B, Campbell L, Boffetta P. 1997. Mortality in employees of a Scottish paper mill. Am J Ind Med 32:535-539.

Coleman M, Douglas A, Hermon C, Peto J. 1986. Cohort study analysis with a FORTRAN computer program. Int J Epidemiol 15:134-137.

Dich J, Hoar Zahm S, Hanberg A, Adami H-O. 1997. Pesticides and cancer. Cancer Causes Control 8:420-443.

Fassa AG, Facchini LA, Dall'Agnol MM. 1998. The Brazilian cohort of pulp and paper workers: the logistic of a cancer mortality study. Cad Saude Publica 14(suppl 3):117-123.

Henneberger PK, Ferris BG Jr, Monson RR. 1989. Mortality among pulp and paper workers in Berlin, New Hampshire. Br J Ind Med 46:658-664.

Henneberger PK, Lax MB. 1998. Lung cancer mortality in a cohort of older pulp and paper workers. Int J Occup Environ Health 4:147-154.

Institute of Medicine, Committee to Review the Health Effects in Vietnam Veterans of Exposure to Herbicides. 2000. Veterans and Agent Orange: Update 2000. Washington, DC:National Academy Press.

Jappinen P, Pukkala E. 1991. Cancer incidence among pulp and paper workers exposed to organic chlorinated compounds formed during chlorine pulp bleaching. Scand J Work Environ Health 17:356-359.

Jappinen P, Tola S. 1986. Smoking among Finnish pulp and paper workers--evaluation of its confounding effect on lung cancer and coronary heart disease rates. Scand J Work Environ Health 12:619-626.

Kauppinen T, Teschke K, Astrakianakis G, Boffetta P, Colin D, Keefe A, et al. 2002. Assessment of exposure in an international study on cancer risks among pulp, paper and paper product workers. Am Ind Hyg Assoc J 63:254-261.

Kauppinen T, Teschke K, Savela A, Kogevinas M, Boffetta P. 1997. International database of exposure measurements in the pulp, paper and paper product industries. Int Arch Occup Environ Health 70:119-127.

Kogevinas M, Becher H, Benn T, Bertazzi PA, Boffetta P, Bueno-de-Mesquita HB, et al. 1997. Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols and dioxins: an expanded and updated international study. Am J Epidemiol 145:1061-1075.

Krishnan R, Meyer C, Goodman B, Foerst MB. 1990. Estimated Worker Exposure to 2378-TCDD and 2378-TCDF in the Manufacture, Processing, and Commercial Use of Pulp, Paper and Paper Products. EPA S60/4-90-015. Washington, DC:U.S. Environmental Protection Agency, Office of Toxic Substances.

Langseth H, Andersen A. 1999. Cancer incidence among women in the Norwegian pulp and paper industry. Am J Ind Med 36:108-113.

Langseth H, Andersen A. 2000. Cancer incidence among male pulp and paper workers in Norway. Scand J Work Environ Health 26:99-105.

Lee WJ, Teschke K, Kauppinen T, Anderson A, Jappinen P, Szadkowska-Stanczyk I, et al. 2002. Mortality from lung cancer of workers exposed to sulfur dioxide in the pulp and paper industry. Environ Health Perspect 110:991-995.

Matanoski GM, Kanchanaraska S, Lees PSJ, Tao X, Royall R, Francis M, et al. 1998. Industry-wide study of mortality of pulp and paper mill workers. Am J Ind Med 33:354-365.

McCunney RJ. 1999. Hodgkin's disease, work, and the environment: a review. J Occup Environ Med 41:36-46.

McLean D, Pearce N, Colin D, Boffetta P. 2002. Mortality and cancer incidence in New Zealand pulp and paper mill workers. NZ Med J 115:186-190.

Milham SJ, Demers P. 1984. Mortality among pulp and paper workers. J Occup Med 26:844-846.

Rix BA, Villadsen E, Engholm G, Lynge E. 1998. Hodgkin's disease, pharyngeal cancer, and soft tissue sarcomas in Danish paper mill workers. J Occup Environ Med 40:55-62.

Rix BA, Villadsen E, Lynge E. 1997. Cancer incidence of sulfite pulp workers in Denmark. Scand J Work Environ Health 23:458-461.

Sala-Serra M, Sunyer J, Kogevinas M, McFarlane D, Anto JM. 1996. Cohort study on cancer mortality among workers in the pulp and paper industry in Catalonia, Spain. Am J Ind Med 30:87-92.

Siemiatycki J, Richardson L, Gerin M, Goldberg M, Dewar R, Desy M, et al. 1986. Association between several sites of cancer and nine organic dusts: results from an hypothesis-generating case-control study in Montreal, 1979-1983. Am J Epidemiol 123:235-249.

Siemiatycki J, Richardson L, Straif K, Latreille B, Lakhani R, Campbell S, et al. 2004. Listing occupational carcinogens. Environ Health Perspect 112:1447-1459.

Siemiatycki J, Wacholder S, Dewar R, Wald L, Begin D, Richardson L, et al. 1988. Smoking and degree of occupational exposure: are internal analyses in cohort studies likely to be confounded by smoking status? Am J Ind Med 13:59-69.

Szadkowska-Stanczyk I, Boffetta P, Wilczynska U, et al. 1997. Cancer mortality among pulp and paper workers in Poland. A cohort study. Int J Occup Med Environ Health 10:19-29.

Szadkowska-Stanczyk I, Szymczak W. 2001. Nested case-control study of lung cancer among pulp and paper workers in relation to exposure to dusts. Am J Ind Med 39:547-556.

Toren K, Persson B, Wingren G. 1996. Health effects of working in pulp and paper mills: malignant diseases. Am J Ind Med 29:123-130.

Toren K, Sallsten G, Jarvholm B. 1991. Mortality from asthma, chronic obstructive pulmonary disease, respiratory system cancer, and stomach cancer among paper mill workers: a case-referent study. Am J Ind Med 19: 729-737.

WHO. 1975. International Classification of Diseases, 9th Revision. Geneva:World Health Organization.

WHO. 2001. WHO Mortality Data Base (MDB), WHO Statistical Information System (WHOSIS). Geneva:World Health Organization. Available: http://www.who.int/whosis/ [accessed June 2001].

Wild P, Bergeret A, Moulin JJ, Lahmar A, Hours M. 1998. Mortality in the French paper and pulp industry. Rev Epidemiol Sante Publique 46:85-92.

David McLean, (1,2) Neil Pearce, (2) Hilde Langseth, (3) Paavo Jappinen, (4) Irena Szadkowska-Stanczyk, (5) Bodil Persson, (6) Pascal Wild, (7) Reiko Kishi, (8) Elsebeth Lynge, (9) Paul Henneberger, (10) Maria Sala, (11) Kay Teschke, (12) Timo Kauppinen, (13) Didier Colin, (1) Manolis Kogevinas, (11) and Paolo Boffetta (1)

(1) International Agency for Research on Cancer, Lyon, France; (2) enter for Public Health Research, Massey University, Wellington, New Zealand; (3) Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway; (4) Stora Enso Oyj, Imatra, Finland; (5) Nofer Institute of Occupational Medicine, Lodz, Poland; (6) Department of Occupational and Environmental Medicine, University Hospital, Linkoping, Sweden; (7) Institut National de Recherche et de Securite, National Research and Safety Institute, Department of Epidemiology, Vandoeuvre, France; (8) Department of Public Health, Hokkaido University Graduate School of Medicine, Hokkaido, Japan; (9) University of Copenhagen, Copenhagen, Denmark; (10) National Institute for Occupational Safety and Health, Morgantown, West Virginia, USA; (11) Municipal Institute of Medical Research, Barcelona, Spain; (12) University of British Columbia, Vancouver, Canada; (13) Finnish Institute of Occupational Health, Helsinki, Finland

Address correspondence to P. Boffetta, Gene-Environment Epidemiology Group, International Agency for Research on Cancer, 150 cours Albert-Thomas, 69372 Lyon Cedex 08, France. Telephone: [phone]. Fax: [phone]. E-mail: [e-mail]

This study was partially supported by grant contracts from the European Commission's Biomed Program (BMH1-CT92-1110 and BMH4-CT95-1100). The Centre for Public Health Research at Massey University is supported by the Health Research Council of New Zealand.

The authors declare they have no competing financial interests.

Received 15 August 2005; accepted 13 March 2006.

Table 1. Distribution of study participants by exposure status and
country.

                                     Volatile organochlorines
               Employment Follow-up  Never exposed (a)
Country        period     period     No.     Person-years

Denmark        1920-1992  1943-1993   1,512  27,258
Finland        1935-1995  1945-1995     927  28,048
France         1921-1992  1968-1992     386   6,009
Japan          1946-1996  1976-1996     567   9,880
New Zealand    1955-1992  1980-1992   3,396  34,792
Norway         1920-1993  1953-1993   2,386  55,430
Poland         1967-1990  1968-1990   3,538  50,850
Scotland       1920-1990  1955-1994     525  12,480
Spain          1955-1991  1970-1992     228   3,946
Sweden         1920-1990  1955-1991     969  17,329
United States  1920-1982  1961-1991     147   2,824
Total                                14,581  248,846

               Volatile organochlorines
               Ever exposed (a)      High exposure (b)
Country        No.     Person-years  No.    Person-years

Denmark         5,762    142,519     2,538   64,274
Finland         6,964    218,387       653   13,664
France          3,260     60,402        36      764
Japan           1,602     29,520       129    2,609
New Zealand     2,583     27,702     1,155   12,388
Norway         16,002    420,322     4,491  120,494
Poland          2,399     37,676       159    2,902
Scotland        3,534     85,965        26      810
Spain           1,199     21,219         8       80
Sweden          2,475     53,210       379    8,323
United States     107      2,014        54    1,127
Total          45,887  1,098,936     9,628  229,434

               Nonvolatile organochlorines
               Never exposed (a)     Ever exposed (a)
Country        No.     Person-years  No.     Person-years

Denmark         2,863   61,791        4,813  115,777
Finland         4,022  124,524        3,180   97,437
France          2,265   37,902        2,119   40,811
Japan           1,097   19,843        1,221   22,396
New Zealand     4,635   47,717        1,067   11,973
Norway          9,942  252,707        6,063  150,908
Poland          4,252   61,350        1,833   29,421
Scotland          414    7,075          604   11,171
Spain           2,379   48,815        1,729   33,830
Sweden            728   16,947        2,151   53,250
United States     625   10,973          160    3,162
Total          33,222  689,645       24,940  570,135

(a) The total number of workers that could be classified by exposure to
volatile (60,468) and nonvolatile (58,162) organochlorines differed.
(b) High exposure is a subset of ever exposure.

Table 2. SMRs for selected causes by exposure to volatile
organochlorine compounds.

Cause of death           Never exposed           Ever exposed
(ICD-9 codes)            Obs    SMR   95% CI     Obs    SMR   95% CI

All causes               2,175  0.88  0.84-0.91  9,350  0.91  0.89-0.93
All neoplasms (140-208)    524  0.91  0.83-0.99  2,285  0.93  0.89-0.97
Oral cavity and              9  0.68  0.31-1.29     33  0.61  0.42-0.86
  pharynx (140-149)
Esophagus (150)             15  0.99  0.56-1.64     45  0.74  0.54-0.99
Stomach (151)               60  0.98  0.75-1.26    201  0.83  0.72-0.95
Colon (153)                 38  0.98  0.69-1.34    140  0.85  0.72-1.01
Rectum (154)                18  0.68  0.40-1.07     98  0.91  0.74-1.10
Liver (155)                 10  0.76  0.37-1.41     33  0.76  0.53-1.07
Gallbladder (156)            6  1.24  0.45-2.69     14  0.66  0.36-1.10
Pancreas (157)              32  1.07  0.74-1.52    115  0.90  0.75-1.09
Larynx (161)                 9  1.18  0.54-2.24     29  1.00  0.67-1.43
Lung (162)                 122  0.85  0.70-1.01    613  1.04  0.96-1.13
Pleura (163)                 4  1.91  0.52-4.90     20  2.00  1.22-3.09
Other respiratory            0  0.00  0.00-2.74     10  1.72  0.82-3.15
  (164-165)
Soft tissue (171)            2  0.88  0.11-3.20     12  1.13  0.59-1.98
Melanoma (172)               9  1.02  0.47-1.94     42  1.12  0.81-1.51
Breast (174-175)             4  0.94  0.26-2.41     63  0.96  0.73-1.22
Cervix uteri (180)           1  0.89  0.02-4.98     17  0.99  0.58-1.59
Prostate (185)              44  0.79  0.58-1.07    177  0.86  0.74-1.00
Penis and other male         1  1.46  0.04-8.11      7  2.51  1.01-5.17
  genital organs (187)
Bladder (188)               17  0.88  0.51-1.40     87  1.09  0.88-1.35
Kidney (189)                12  0.77  0.40-1.34     54  0.77  0.58-1.01
Brain (191-192)             16  1.02  0.58-1.66     68  0.98  0.76-1.25
Lymphatic and               45  0.96  0.70-1.28    189  0.94  0.81-1.08
  hematopoietic
  (200-208)
NHL (200, 202)              15  1.12  0.63-1.86     52  0.86  0.64-1.13
Hodgkin disease (201)        4  0.94  0.26-2.42     21  1.07  0.66-1.63
Multiple myeloma (203)       7  0.76  0.31-1.58     41  1.02  0.73-1.38
Leukemia (204-208)          19  0.99  0.60-1.55     75  0.93  0.73-1.17
Circulatory system       1,042  0.91  0.86-0.97  4,444  0.95  0.92-0.98
  diseases (390-459)
Respiratory system         130  0.77  0.64-0.91    561  0.82  0.75-0.89
  diseases (460-519)
Digestive system            60  0.71  0.54-0.91    299  0.85  0.75-0.95
  diseases (520-579)
Liver cirrhosis (571)       23  0.77  0.49-1.16    119  0.95  0.79-1.14

Cause of death           High exposure (a)
(ICD-9 codes)            Obs    SMR   95% CI

All causes               1,902  0.90  0.86-0.95
All neoplasms (140-208)    517  1.01  0.93-1.10
Oral cavity and             11  1.09  0.54-1.95
  pharynx (140-149)
Esophagus (150)              6  0.57  0.21-1.24
Stomach (151)               43  0.95  0.69-1.28
Colon (153)                 35  0.90  0.63-1.25
Rectum (154)                30  1.19  0.80-1.70
Liver (155)                  6  0.83  0.31-1.82
Gallbladder (156)            4  1.05  0.29-2.70
Pancreas (157)              19  0.71  0.42-1.10
Larynx (161)                 3  0.65  0.13-1.89
Lung (162)                 125  1.06  0.88-1.26
Pleura (163)                 8  3.67  1.58-7.23
Other respiratory            4  3.84  1.05-9.84
  (164-165)
Soft tissue (171)            4  1.75  0.48-4.48
Melanoma (172)               6  0.63  0.23-1.37
Breast (174-175)             6  0.61  0.22-1.32
Cervix uteri (180)           2  0.67  0.08-2.40
Prostate (185)              49  1.02  0.76-1.35
Penis and other male         2  3.11  0.38-11.2
  genital organs (187)
Bladder (188)               20  1.07  0.65-1.65
Kidney (189)                15  0.97  0.54-1.59
Brain (191-192)             20  1.25  0.76-1.93
Lymphatic and               41  0.92  0.66-1.25
  hematopoietic
  (200-208)
NHL (200, 202)              11  0.84  0.42-1.51
Hodgkin disease (201)        4  0.93  0.25-2.39
Multiple myeloma (203)       9  1.00  0.46-1.90
Leukemia (204-208)          17  0.95  0.55-1.51
Circulatory system         877  0.92  0.86-0.98
  diseases (390-459)
Respiratory system          97  0.72  0.59-0.88
  diseases (460-519)
Digestive system            47  0.68  0.50-0.91
  diseases (520-579)
Liver cirrhosis (571)       24  1.00  0.64-1.48

Obs, observed.
(a) High exposure is a subset of ever exposure.

Table 3. SMRs for selected causes by exposure to nonvolatile
organochlorine compounds.

Cause of death            Never exposed           Ever exposed
(ICD-9 codes)             Obs    SMR   95% CI     Obs    SMR   95% CI

All causes                5,771  0.89  0.87-0.91  4,622  0.94  0.91-0.96
All neoplasms (140-208)   1,434  0.94  0.89-0.99  1,145  0.94  0.89-1.00
  Oral cavity and            33  0.92  0.63-1.29     15  0.51  0.29-0.85
    pharynx (140-149)
  Esophagus (150)            27  0.71  0.41-1.03     26  0.78  0.51-1.15
  Stomach (151)             146  0.93  0.79-1.10     98  0.89  0.72-1.08
  Colon (153)               106  1.04  0.85-1.25     62  0.74  0.57-0.95
  Rectum (154)               60  0.87  0.66-1.12     51  0.96  0.71-1.26
  Liver (155)                27  0.87  0.57-1.27     16  0.69  0.40-1.13
  Pancreas (157)             67  0.84  0.65-1.06     69  1.12  0.87-1.42
  Larynx (161)               18  0.92  0.54-1.45     20  1.23  0.75-1.90
  Lung (162)                356  0.98  0.88-1.08    314  1.04  0.93-1.17
  Pleura (163)               17  2.78  1.62-4.45      4  0.78  0.21-2.01
  Other respiratory           8  2.11  0.91-4.16      2  0.66  0.08-2.39
    (164-165)
  Soft tissue (171)           8  1.22  0.53-2.41      4  0.80  0.22-2.04
  Melanoma (172)             20  0.82  0.50-1.27     21  1.17  0.72-1.78
  Breast (174-175)           21  0.90  0.55-1.37     32  0.89  0.61-1.25
  Prostate (185)            117  0.85  0.70-1.02     84  0.93  0.74-1.15
  Penis and other male        2  1.12  0.14-4.05      5  3.60  1.17-8.40
    genital organs (187)
  Bladder (188)              50  1.00  0.74-1.32     43  1.09  0.79-1.46
  Kidney (189)               41  0.94  0.67-1.27     18  0.53  0.31-0.83
  Brain (191-192)            44  1.02  0.74-1.37     28  0.80  0.53-1.15
  Lymphatic and             112  0.88  0.72-1.05     97  0.99  0.81-1.21
    hematopoietic
    (200-208)
    NHL (200, 202)           35  0.93  0.65-1.30     25  0.86  0.55-1.26
    Hodgkin disease           7  0.58  0.23-1.19     17  1.76  1.02-2.82
      (201)
    Multiple myeloma         21  0.83  0.51-1.27     20  1.07  0.66-1.66
      (203)
    Leukemia (204-208)       49  0.95  0.70-1.26     35  0.89  0.62-1.24
Circulatory system        2,727  0.92  0.89-0.96  2,157  0.99  0.95-1.04
  diseases (390-459)
Respiratory system          327  0.78  0.69-0.86    266  0.82  0.72-0.92
  diseases (460-519)
Digestive system            167  0.74  0.63-0.86    166  0.91  0.77-1.05
  diseases (520-579)

Obs, observed.

Table 4. Mortality from selected causes by weighted cumulative exposure
to volatile organochlorines.

                              Weighted cumulative exposure to volatile
                              organochlorines (a)
                              < 1 ppm-years (b)  1-17 ppm-years
Cause of death (ICD-9 codes)  Obs    RR (c)      Obs  RR    95% CI

All neoplasms (140-208)       1,006  1           778  1.12  (1.01-1.24)
Esophagus (150)                  26  1            14  0.94  (0.46-1.90)
Liver (155)                      18  1             9  1.05  (0.42-2.65)
Lung (162)                      253  1           236  1.15  (0.95-1.39)
Pleura (163)                      6  1             6  1.16  (0.36-3.78)
Lymphatic and hematopoietic      90  1            66  1.09  (0.78-1.54)
  (200-208)
NHL (200, 202)                   25  1            18  1.15  (0.60-2.22)

                              Weighted cumulative exposure to volatile
                              organochlorines (a)
                              > 18 ppm-years
Cause of death (ICD-9 codes)  Obs  RR    95% CI       Trend (d)

All neoplasms (140-208)       489  1.19  (1.06-1.34)  0.002
Esophagus (150)                 5  0.54  (0.19-1.51)  0.289
Liver (155)                     6  1.45  (0.51-4.16)  0.525
Lung (162)                    120  1.07  (0.85-1.36)  0.394
Pleura (163)                    8  2.49  (0.83-7.53)  0.114
Lymphatic and hematopoietic    33  0.93  (0.61-1.42)  0.859
  (200-208)
NHL (200, 202)                  9  0.97  (0.43-2.20)  0.955

Obs, observed.
(a) Weighted cumulative exposure ([SIGMA] prevalence x level x
duration). (b) Reference category. (c) RR adjusted for sex, age,
employment status, calendar year, and country. (d) p-Value of test for
linear trend.